Concepedia

Fred Poordad

FP

Statistics

Publications

24

Citations

1.1K

H-Index

16

Active since

2006

Affiliations

Cedars-Sinai Medical Center(Current)

The University of Texas Health Science Center at San Antonio

Seno Medical (United States)

Goethe University Frankfurt

Hôpital Beaujon

Fred Poordad is an author at Cedars-Sinai Medical Center specializing in medicine, hepatitis, and viral hepatitis.

Top concepts

Publications per year

2006–2021

24

Publications

24

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

Stefan Zeuzem, Graham R. Foster, Stanley Wang et al. · New England Journal of Medicine · 2018 · 426 citations · Full text

1413 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR TREATMENT OF CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-2, A PHASE III TRIAL

M.P. Manns, Patrick Marcellin, Fred Poordad et al. · Journal of Hepatology · 2013 · 121 citations

, , +8

BMS‐986263 in patients with advanced hepatic fibrosis: 36‐week results from a randomized, placebo‐controlled phase 2 trial

Eric Lawitz, Diane E. Shevell, Giridhar Tirucherai et al. · Hepatology · 2021 · 89 citations · Full text

Screening for hepatitis B in chemotherapy patients: survey of current oncology practices

Thao Tran, Mina O. Rakoski, Paul Martin et al. · Alimentary Pharmacology & Therapeutics · 2009 · 59 citations

Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin

Ira M. Jacobson, Patrick Marcellin, Stefan Zeuzem et al. · Hepatology · 2012 · 51 citations

1–5 of 24